| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |